Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
![](https://sciaxis.org/wp-content/uploads/2023/05/portrait-person-wearing-medical-gown-holding-pills.jpg)
![](https://sciaxis.org/wp-content/uploads/2023/05/portrait-person-wearing-medical-gown-holding-pills.jpg)
Hereditary transthyretin (ATTR variant) amyloidosis, also called hATTR amyloidosis is a rare, rapidly progressive, debilitating, and fatal disease caused by transthyretin (TTR) gene variants. Misfolded TTR accumulates as amyloid